
Company valuation, historical trends, and peer comparisons.
According to Xencor, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.23B. This represents a change of 92.98% compared to the average of 1.16B of the last 4 quarters.
The mean historical Enterprise Value of Xencor, Inc. over the last ten years is 1.63B. The current 2.23B Enterprise Value has changed 36.89% with respect to the historical average. Over the past ten years (40 quarters), XNCR's Enterprise Value was at its highest in in the June 2019 quarter at 2.46B. The Enterprise Value was at its lowest in in the June 2025 quarter at 607.32M.
Average
1.63B
Median
1.62B
Minimum
1.01B
Maximum
2.34B
Discovering the peaks and valleys of Xencor, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.11%
Maximum Annual Enterprise Value = 2.34B
Minimum Annual Increase = -30.17%
Minimum Annual Enterprise Value = 1.01B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.27B | -24.65% |
| 2024 | 1.69B | 28.28% |
| 2023 | 1.31B | -15.71% |
| 2022 | 1.56B | -30.17% |
| 2021 | 2.23B | -4.76% |
| 2020 | 2.34B | 23.09% |
| 2019 | 1.90B | -0.66% |
| 2018 | 1.92B | 89.88% |
| 2017 | 1.01B | -5.78% |
| 2016 | 1.07B | 92.11% |
The current Enterprise Value of Xencor, Inc. (XNCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.42B
5-year avg
1.61B
10-year avg
1.63B
Xencor, Inc.’s Enterprise Value is less than Genmab A/S (37.91B), greater than Nektar Therapeutics (1.19B), greater than Nurix Therapeutics, Inc. (2.17B), greater than MacroGenics, Inc. (75.66M), greater than Compugen Ltd. (179.35M), greater than Immutep Limited (-35403649.00), greater than Adagene Inc. (-32219069.00), less than Celldex Therapeutics, Inc. (2.25B), greater than Immunocore Holdings plc (1.49B), greater than Innate Pharma S.A. (129.06M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 37.91B | $34.24B | |
| 1.19B | $1.10B | |
| 2.17B | $2.82B | |
| 75.66M | $154.47M | |
| 179.35M | $186.61M | |
| -35403649.00 | $22.88M | |
| -32219069.00 | $89.60M | |
| 2.25B | $2.29B | |
| 1.49B | $1.54B | |
| 129.06M | $151.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xencor, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xencor, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Xencor, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Xencor, Inc. (XNCR)?
What is the 3-year average Enterprise Value for Xencor, Inc. (XNCR)?
What is the 5-year average Enterprise Value for Xencor, Inc. (XNCR)?
How does the current Enterprise Value for Xencor, Inc. (XNCR) compare to its historical average?